Enrollment Benchmarks
Benchmark data and performance comparisons for enrollment rates, screen failure metrics, and site activation timelines across therapeutic areas and trial phases.
Benchmarks by Therapeutic Area
Network-wide enrollment benchmarks updated quarterly, based on de-identified performance data from active studies across our site network.
42 active studies
Enrollment Rate: 1.8 patients/site/month
Screen Failure Rate: 28% | Avg. Site Activation: 22 days
28 active studies
Enrollment Rate: 1.2 patients/site/month
Screen Failure Rate: 38% | Avg. Site Activation: 26 days
19 active studies
Enrollment Rate: 2.1 patients/site/month
Screen Failure Rate: 22% | Avg. Site Activation: 19 days
15 active studies
Enrollment Rate: 2.4 patients/site/month
Screen Failure Rate: 25% | Avg. Site Activation: 17 days
11 active studies
Enrollment Rate: 0.6 patients/site/month
Screen Failure Rate: 44% | Avg. Site Activation: 31 days
13 active studies
Enrollment Rate: 1.9 patients/site/month
Screen Failure Rate: 20% | Avg. Site Activation: 18 days
Our Benchmarking Methodology
Our benchmarks are derived from standardized data collection across the network.
Data Sources
De-identified site-level data from CTMS integrations, enrollment tracking systems, and regulatory milestone databases across 247 active network sites.
Update Frequency
Benchmarks are recalculated quarterly with a rolling 12-month lookback window. Seasonal adjustments are applied where enrollment patterns show cyclical variation.
Peer Comparison
Sites receive confidential benchmark reports comparing their performance to network medians, top-quartile thresholds, and therapeutic area-specific targets.
Access Detailed Benchmarks
Request access to our full benchmark dataset with protocol-level detail and custom therapeutic area comparisons.